News + Filings Holdings
All
13F
13D/G
Other
|
|
MILLER VALUE PARTNERS, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/08/2022 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 0% stake in WW INTERNATIONAL, INC. |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/10/2022 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 0% stake in Tivity Health, Inc. |
| 02/14/2022 |
SC 13G
| MILLER VALUE PARTNERS, LLC reports a 5.9% stake in WW INTERNATIONAL, INC. |
| 02/14/2022 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 7.4% stake in Tivity Health, Inc. |
| 02/14/2022 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 4.5% stake in GTY Technology Holdings Inc. |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/12/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 1.7% stake in Ziopharm Oncology, Inc. |
| 10/12/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 2% stake in Quotient Technology Inc. |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 8.5% stake in Flexion Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 3.8% stake in Precigen, Inc. |
| 02/16/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 7.4% stake in Ziopharm Oncology, Inc. |
| 02/16/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 6.2% stake in Tivity Health, Inc. |
| 02/16/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 7.1% stake in Quotient Technology Inc. |
| 02/16/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 0.3% stake in Medifast, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/16/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2020 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 8.9% stake in Ziopharm Oncology, Inc. |
| 02/14/2020 |
SC 13G
| MILLER VALUE PARTNERS, LLC reports a 8% stake in Tivity Health, Inc. |
|
|
|